neurology

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/172

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 2:26 AM on 4/12/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

173 Terms

1
New cards

donepezil: brand

[aricept]

2
New cards

donepezil [aricept]: class

reversible acetylcholinesterase inhibitors [AChE-I]; CNS-selective noncompetitive

3
New cards

donepezil [aricept]: indications

mild to severe alzheimers

4
New cards

donepezil [aricept]: MOA

blocks acetylcholinesterase and metabolism of acetylcholine

5
New cards

donepezil [aricept]: contraindications

not be used in patients w/ bradycardia, known cardiac conduction system disease due to risk of syncope, falls, fractures

6
New cards

donepezil [aricept]: BBW

none

7
New cards

donepezil [aricept]: common ADRs

cholinergic [SLUDGE: sialorrhea, lacrimation, urination, defecation, GI, emesis], CNS: headache, insomnia, vivid dreams; cardiac: bradycardia, syncope, heart block, hypotension; GI: anorexia, weight lost

8
New cards

donepezil [aricept]: rare ADRs

rhabdomyolysis, neuroleptic malignant syndrome

9
New cards

donepezil [aricept]: counseling

none

10
New cards

memantine: brand

[namenda]

11
New cards

memantine [namenda]: class

n-methyl-D-aspartate [NMDA] receptor antagonist

12
New cards

memantine [namenda]: indications

alzheimers

13
New cards

memantine [namenda]: MOA

uncompetitive NMDA receptor antagonist, blocks excessive glutamate-induced calcium influx by binding the NMDA channel pore, prevents excitotoxicity w/o affecting normal neurotransmission

14
New cards

memantine [namenda]: contraindications

caution in patients w/ a history of seizure disorder: may increase risk of seizures; use w/ caution w/ CV disease; renal impairment; hepatic impairment; may increase urine pH

15
New cards

memantine [namenda]: BBW

none

16
New cards

memantine [namenda]: common ADRs

headache, dizziness, diarrhea, constipation, confusion

17
New cards

memantine [namenda]: rare ADRs

none

18
New cards

memantine [namenda]: counseling

none

19
New cards

gabapentin: brand

[neurontin, gralise]

20
New cards

gabapentin [neurontin, gralise]: class

antiseizure agent, misc, GABA analog

21
New cards

gabapentin [neurontin, gralise]: indications

neuropathic pain

22
New cards

gabapentin [neurontin, gralise]: MOA

gabapentin looks like GABA, blocks calcium to calm excitory signals; hepls to control pain and seizure

23
New cards

gabapentin [neurontin, gralise]: contraindications

withdrawal, products aren't interchangeable, masthenia gravis, renal impairment, history of substane misuse

24
New cards

gabapentin [neurontin, gralise]: BBW

none

25
New cards

gabapentin [neurontin, gralise]: common ADRs

drowsiness, dizziness, peripheral edema, weight gain, dental disease, diarrhea, dyspepsia, nausea, vomiting, erectile dysfunction, abnormal gait, depression, memory impairment, diplopia, nystagmus

26
New cards

gabapentin [neurontin, gralise]: rare ADRs

respiratory depression, accidental injury, allergic reaction like rashes, drug reaction w/ eosinophilia and system symptoms [DRESS], sjs, toxic epidermal necrolysis, bullous pemphigoid, erythema multiforme, hypersensitivity anglitis, agitation

27
New cards

gabapentin [neurontin, gralise]: counseling

none

28
New cards

pregabalin: brand

[lyrica]

29
New cards

pregabalin [lyrica]: class

antiseizure agent, misc.; GABA analog

30
New cards

pregabalin [lyrica]: indications

neuropathic pain

31
New cards

pregabalin [lyrica]: MOA

calms the CNS by blocking calcium, not by acting on GABA

32
New cards

pregabalin [lyrica]: contraindications

angioedema, renal impairment, substance misuse, withdrawal

33
New cards

pregabalin [lyrica]: BBW

none

34
New cards

pregabalin [lyrica]: common ADRs

drowsiness, dizziness, edema

35
New cards

pregabalin [lyrica]: rare ADRs

respiratory depression, CNS depression: accidental injury, maculopapular rashes, DRESS, sjs, toxic epidermal necrolysis, peripheral edema, blurred vision, decreased visual acuity, diplopia, visual field loss, weight gain

36
New cards

pregabalin [lyrica]: counseling

none

37
New cards

metaxalone: brand

[skelexin]

38
New cards

metaxalone [skelexin]: class

skeletal muscle relaxant

39
New cards

metaxalone [skelexin]: indications

spasticity

40
New cards

metaxalone [skelexin]: MOA

not established

41
New cards

metaxalone [skelexin]: contraindications

CNS depression, serotonin syndrome, hepatic impairment, renal impairment

42
New cards

metaxalone [skelexin]: BBW

none

43
New cards

metaxalone [skelexin]: common ADRs

dizziness, drownsiness, headache

44
New cards

metaxalone [skelexin]: rare ADRs

serotonine syndrome

45
New cards

metaxalone [skelexin]: counseling

none

46
New cards

dexmethylphenidate: brand

[focalin]

47
New cards

dexmethylphenidate [focalin]: class

central nervous system stimulant

48
New cards

dexmethylphenidate [focalin]: indications

ADHD: stimulants

49
New cards

dexmethylphenidate [focalin]: MOA

Dexmethylphenidate = the active half of methylphenidate that boosts & blocks reuptake of NE and dopamine

50
New cards

dexmethylphenidate [focalin]: contraindications

misuse, abuse, substance use disorder, hypersensitivity, rare hereditary problems to galactose malaborption, or sucrose-isomaltase insufficiency

51
New cards

dexmethylphenidate [focalin]: BBW

concurrent use of MAO inhibitor, visual disturbance, amphetamines, ocular effects, peripheral vasculopathy, bipolar disorder, CV disorders, seizure disorder, tourette syndrome, preexisting severe GI narrowing conditions

52
New cards

dexmethylphenidate [focalin]: common ADRs

dizziness, headache, upset stomach, weight loss, anxiety, decreased appetite, insomnia, heartburn, nose/throat irritation, increased blood pressure/heart rate, palpitations, hyperhidrosis, decreased libido, bruxism, mood changes, tremor, restlessness, agitation

53
New cards

dexmethylphenidate [focalin]: rare ADRs

CV events, aute MI, sudden cardiac death, stroke, tachycardia, increaed BP, growth retardation, priapism, psychosis or mania

54
New cards

dexmethylphenidate [focalin]: counseling

none

55
New cards

dexmethylphenidate [focalin]: alternatives

- lisdexamfetamine [vyvanse]

- methylphenidate [ritalin, concerta]

56
New cards

guanfacine: brand

[estulic, tenex]

57
New cards

guanfacine [estulic, tenex]: class

alpha-adrenergic agonist; antihypertensive

58
New cards

guanfacine [estulic, tenex]: indications

ADHD

59
New cards

guanfacine [estulic, tenex]: MOA

calms the brain and body to improve focus without stimulation; decreases sympathetic outflow

60
New cards

guanfacine [estulic, tenex]: contraindications

severe coronary insufficiency, recent MI, history of bradycardia, CV disease, heart block, hypotension, syncope, CV disease, chronic renal or hepatic impairment

61
New cards

guanfacine [estulic, tenex]: BBW

dizziness, drowsiness, headache, constipation, xerostomia, impotence, fatigue, insomnia, abdominal pain, decreased appetite

62
New cards

guanfacine [estulic, tenex]: common ADRs

CV effects: AV block, bradycardia, hypotension, orthostatic hypotension, sinoatrial nodal rhythm disorder, and syncope may occur, drowsiness, insomnia, sedated state, headache, anxiety, rebound hypertension

63
New cards

guanfacine [estulic, tenex]: rare ADRs

none

64
New cards

guanfacine [estulic, tenex]: counseling

none

65
New cards

carbamazepine: brand

[tegretol]

66
New cards

carbamazepine [tegretol]: class

sodium channel blocker/modulator

67
New cards

carbamazepine [tegretol]: indications

anti-epileptic

68
New cards

carbamazepine [tegretol]: MOA

hepatic enzyme inducers

69
New cards

carbamazepine [tegretol]: contraindications

hypersensitivity, history of bone marrow depression, co-tretment w/ MAOIs, nefazodone, other NNRTIs that are CYP3A4 substrates

70
New cards

carbamazepine [tegretol]: BBW

agranulotcytosis, aplastic anemia, dermatological rxns such as sjs/ten [especially in asians]

71
New cards

carbamazepine [tegretol]: common ADRs

CNS depression, dizziness, diplopia, blurred vision, nausea, ataxia, hyponatremia, elevated LFTs

72
New cards

carbamazepine [tegretol]: rare ADRs

see BBW

73
New cards

carbamazepine [tegretol]: counseling

see ADRs

74
New cards

carbamazepine [tegretol]: alternatives

- oxcarbazepine [trileptal]

- lacosamide [vimpat]

- lamotrigine [lamictal]

- phenytoin [dilantin]

75
New cards

oxcarbazepine [trileptal]: contraindications

hypersensitivity

76
New cards

oxcarbazepine [trileptal]: common ADRs

CNS depression, dizziness, diplopia, nausea, ataxia, hyponatremia, weight gain, alopecia

77
New cards

oxcarbazepine [trileptal]: rare ADRs

agranulocytosis, dermatological rxn

78
New cards

oxcarbazepine [trileptal]: counseling

see ADRs

79
New cards

lacosamide [vimpat]: contraindications

hypersensitivity to lacosamide

80
New cards

lacosamide [vimpat]: common ADRs

CNS depression, dizziness, headache, nausea, diplopia, ataxia

81
New cards

lacosamide [vimpat]: rare ADRs

cardiac arrhythmias, hypersensitivit rxns

82
New cards

lacosamide [vimpat]: counseling

see ADRs

83
New cards

lamotrigine [lamictal]: contraindications

hypersensitivity to lamotrigine

84
New cards

lamotrigine [lamictal]: BBW

serious skin reactions [including sjs]

85
New cards

lamotrigine [lamictal]: common ADRs

CNS depression, nausea

86
New cards

lamotrigine [lamictal]: rare ADRs

see BBW, blood dyscrasias

87
New cards

lamotrigine [lamictal]: counseling

see ADRs, call doc if any new rash/skin changes, concomitant use with divalproex increased lamotrigine lvls: increases risk of serious skin rxns

88
New cards

phenytoin [dilantin]: contraindications

hypersensitivity to phenytoin, sinus bradycardia, AV block

89
New cards

phenytoin [dilantin]: BBW

hypotension, arrhythmias w/ IV administration

90
New cards

phenytoin [dilantin]: common ADRs

gingival hyperplasia, bone marrow hypoplasia, osteoporosis, CNS depression, ataxia, nausea, vomiting, rash, headaches, hormonal dysfunction, vit. K, and folate deficiencies

91
New cards

phenytoin [dilantin]: rare ADRs

blood dyscrasias, hepatotoxicity, delayed hypersensitivity rxns, local inj. site reaction

92
New cards

phenytoin [dilantin]: counseling

see ADRs

93
New cards

divalproex: brand

[depakote]

94
New cards

divalproex [depakote]: class

GABA modulator

95
New cards

divalproex [depakote]: contraindications

hypersensitivity to divalproex, hepatic disease, urea cycle disorders

96
New cards

divalproex [depakote]: BBW

hepatotoxicity, patients with mitochondrial disease, teratogenicity, pancreatitis

97
New cards

divalproex [depakote]: common ADRs

CNS depression, nausea, tremor, irritability, weight gain, alopecia, hair texture changes, hormone changes

98
New cards

divalproex [depakote]: rare ADRs

see ADRs

99
New cards

phenobarbital: brand

[luminal]

100
New cards

phenobarbital [luminal]: class

GABA receptor agonist [barbiturate]